GABA Modulators – Talk Bio

Actionable Insights Powered by AI

Draig Therapeutics Raises $140M Series A to Advance Neuropsychiatric Drug Pipeline

1 month ago talkbio0Tagged AMPA receptor modulator, Cardiff University, Draig, DT-101, GABA Modulators, Mental Depression, neuropsychiatric drugs, SV Health Investors

Draig Therapeutics; $140M Series A; neuropsychiatric drugs; DT-101; depression treatment; AMPA receptor modulator; GABA modulators; biotech funding; Cardiff University; SV Health Investors

Newleos Therapeutics Launches with $93.5M to Advance Novel Neuropsychiatric Treatments

5 months ago talkbio0Tagged Anxiety Disorders, assets, Funding, GABA Modulators, mental health, Neuropsychiatry, Newleos, Roche (company), Series, Substance Use Disorders

Newleos Therapeutics, mental health, neuropsychiatry, Roche assets, Series A funding, anxiety disorders, substance use disorders, GABA modulators